Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

Contributed by: Business Wire

Logo

Tags

Biotechnology

Technology

Professional Services

Health

Pharmaceutical

Venture Capital

Health Technology

Research

Artificial Intelligence

Science

Finance

Financing

More Like This

Variational AI Releases Enki 4: Major Update to Foundation Model for Small-Molecule Drug Discovery

Variational AI Enters Collaboration with Merck to Apply Generative AI to Drug Discovery

PR Newswire associated0

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery

Tres Alchemix Co. Ltd.

Tres Alchemix Closes $4.4 Million Series A To Advance AI Drug-Design Platform

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

PR Newswire associated0

AI Governance Startup DAIKI GmbH Raises €1.5 Million in Seed Funding

PR Newswire associated0

Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA

PR Newswire associated0

Valinor and Renew Launch Partnership to Generate Largest Clinical Multi-Omics Dataset for Neurological Disease Model Development